Petco Health & Wellness Company, Inc.

Listed Company

WOOFCIK 0001826470NasdaqAcceleratedRetail-Retail Stores, NecDelawareFY ends Jan 30

Period

FY 2026

Revenue

$5.96B

Net Income

$9.07M

Total Assets

$5.17B

Equity

$1.16B

Shares Out

—

Op. Cash Flow

$314.05M

Business

Petco Health & Wellness Company, Inc. is a pet specialty retailer providing an integrated omnichannel platform of products, services, and solutions for pets and pet parents. It sells national and owned brands—pet nutrition, supplies and companion animals—and provides veterinary care, grooming, training, prescriptions and insurance. Its operations include pet care centers, full‑service veterinary hospitals, Vetco clinics, owned‑brand assortments, and the Vital Care membership and retail media programs. It serves the U.S., Puerto Rico, Mexico and Chile via physical stores, e‑commerce and fulfillment options like BOPUS and same‑day delivery.

Summary from filing dated 2025-03-31

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2026 2026-01-31	FY 2025 2025-01-31	FY 2024 2024-01-31	FY 2023 2023-01-31	FY 2022 2022-01-31
Total net sales	5,961	6,116	6,255	6,036	5,807
Total cost of sales	3,656	3,792	3,901	3,609	3,381
Gross profit	2,305	2,324	2,354	2,427	2,427
Selling, general and administrative expenses	2,185	2,317	2,312	2,202	2,161
Goodwill impairment	0	—	1,223	0	0
Operating income (loss)	120	7	−1,180	226	266
Interest income	−6	−4	−3	−1	−62,000
Interest expense	131	144	151	102	—
Loss on partial extinguishment of debt	600,000	—	900,000	—	21
Other non-operating income	0	−5	−5	13	−34
Loss before income taxes and income from equity method investees	−5	−128	−1,324	112	202
Income tax expense (benefit)	6	−7	−28	35	53
Income from equity method investees	−20	−19	−16	−13	−11
Consolidated net income (loss)	9	−102	−1,280	90	160
Net income (loss) attributable to Class A and B-1 common stockholders	9	−102	−1,280	91	164
Basic (per share)	0.03	−0.37	−4.78	0.34	0.62
Diluted (per share)	0.03	−0.37	−4.78	0.34	0.62
Basic (shares)	280	273	268	266	264,261
Diluted (shares)	286	273	268	266	265,338

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2026 2026-01-31	FY 2025 2025-01-31	FY 2024 2024-01-31	FY 2023 2023-01-31	FY 2022 2022-01-31
Cash and cash equivalents	257	166	125	202	212
Receivables, less allowance for credit losses ($779 and $1,594, respectively)	46	40	44	50	56
Merchandise inventories, net	590	653	685	652	675
Prepaid expenses	52	54	59	51	42
Other current assets	75	61	39	61	86
Total current assets	1,020	974	952	1,016	1,071
Fixed assets, net	656	725	816	803	727
Operating lease right-of-use assets	1,289	1,302	1,384	1,398	1,338
Goodwill	980	980	980	2,194	2,184
Trade name	1,025	1,025	1,025	1,025	1,025
Other long-term assets	204	188	206	177	153
Total assets	5,173	5,194	5,363	6,613	6,498
Accounts payable and book overdrafts	451	493	485	381	404
Accrued salaries and employee benefits	154	157	101	90	151
Accrued expenses and other liabilities	205	177	200	218	211
Current portion of operating lease liabilities	320	306	311	310	266
Current portion of long-term debt and other lease liabilities	5	5	16	23	22
Total current liabilities	1,134	1,139	1,113	1,021	1,053
Senior secured credit facilities, net, excluding current portion	1,489	1,578	1,576	1,628	1,640
Operating lease liabilities, excluding current portion	1,047	1,037	1,117	1,148	1,096
Deferred taxes, net	235	218	252	303	318
Other long-term liabilities	104	109	121	130	134
Total liabilities	4,009	4,081	4,179	4,231	4,242
Commitments and contingencies (Notes 7 and 14)	—	—	—	—	—
Preferred stock, $0.001 par value: Authorized - 25.0 million shares; Issued and outstanding - none	—	—	—	—	—
Additional paid-in-capital	2,312	2,280	2,230	2,152	2,134
Accumulated deficit	−1,140	−1,149	−1,047	233	142
Accumulated other comprehensive loss	−8	−18	2	−4	−2
Total stockholders equity	1,164	1,114	1,184	2,381	2,274
Total liabilities and stockholders' equity	5,173	5,194	5,363	6,613	6,498

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2026 2026-01-31	FY 2025 2025-01-31	FY 2024 2024-01-31	FY 2023 2023-01-31	FY 2022 2022-01-31
Depreciation and amortization	197	209	204	194	172
Amortization of debt discounts and issuance costs	5	5	5	5	6
Provision for deferred taxes	17	−30	−54	−893,000	38
Equity-based compensation expense	33	50	82	61	49
Amounts reclassified out of accumulated other comprehensive loss (Note 8)	−556,000	−3	−488,000	168,000	—
Non-cash operating lease costs	412	414	429	423	422
Other non-operating income	0	−5	−5	13	−34
Receivables	−6	4	5	6	−14
Merchandise inventories	63	31	−32	23	−136
Prepaid expenses and other assets	818,000	−4	−8	−6	−18
Accounts payable and book overdrafts	−43	8	104	−23	72
Accrued salaries and employee benefits	−3	57	11	−51	11
Accrued expenses and other liabilities	25	−12	−8	14	43
Operating lease liabilities	−371	−418	−447	−386	−418
Other long-term liabilities	−4	−7	3	−3	−15
Net cash provided by operating activities	314	178	216	346	358
Cash paid for fixed assets	−127	−128	−226	−278	−239
Cash paid for acquisitions, net of cash acquired (Note 3)	—	−629,000	−7	−10	−4
Cash paid for investment	—	−457,000	—	—	—
Proceeds from investments	—	998,000	25	—	6
Proceeds from sale of assets	3	1	—	2	226,000
Cash received from partial surrender of officers' life insurance	—	3	—	—	—
Net cash used in investing activities	−125	−124	−207	−320	−237
Borrowings under long-term debt agreements	—	201	273	123	1,700
Repayments of long-term debt	−95	−201	−348	−140	−1,691
Debt refinancing costs	—	−3	—	—	−25
Payments for finance lease liabilities	−6	−6	−6	−5	−4
Proceeds from employee stock purchase plan and stock option exercises	4	4	4	4	4
Tax withholdings on stock-based awards	−5	−6	−9	−16	−33,000
Proceeds from issuance of common stock	—	3	—	—	—
Net cash used in financing activities	−102	−9	−85	−34	−19
Net increase (decrease) in cash, cash equivalents and restricted cash	88	45	−77	−8	102
Interest paid, net	125	139	142	89	65
Capitalized interest	844,000	729,000	1	1	1
Accounts payable and accrued expenses for capital expenditures	16	13	19	29	37

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro